AGRX - Short-Term Catalyst And Long-Term M&A Potential Make Agile Therapeutics An Attractive Potential Takeover Target
Agile Therapeutics is a US biotech company based in Princeton, New Jersey. It currently has one leading candidate, Twirla, which is a weekly, “lower dose estrogen” contraception patch for women to avoid unwanted pregnancies. Currently it is waiting for FDA’s final decision with a PDUFA date of Feb.16th, 2020.
Twirla has experienced an unusually rough path for the past 8 years (Fig. 1). Its original NDA submission can be dated back to 2012. Since then it has received FDA’s complete response letter ("CRL") twice, indicating a difficult and unpleasant journey. We would assume